表紙
市場調查報告書

輸血診斷的全球市場:產業分析,規模,佔有率,成長,趨勢,預測

Blood Transfusion Diagnostics Market (Product Type - Instruments and Kits, Reagents; Application - Blood Grouping, Disease Screening; End use) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 555311
出版日期 內容資訊 英文 155 Pages
商品交期: 最快1-2個工作天內
價格
輸血診斷的全球市場:產業分析,規模,佔有率,成長,趨勢,預測 Blood Transfusion Diagnostics Market (Product Type - Instruments and Kits, Reagents; Application - Blood Grouping, Disease Screening; End use) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2018年04月10日內容資訊: 英文 155 Pages
簡介

本報告提供全球輸血診斷市場相關調查,市場概要,市場成長的各種影響因素及市場機會分析,各產品種類、應用、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 序論

第2章 前提條件、調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
    • 產品概要
    • 產業發展
    • 主要市場指標
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
  • 市場收益預測
  • 波特的五力分析
  • 價值鏈分析
  • 市場展望

第5章 全球輸血診斷市場分析、預測:各產品種類

  • 主要調查結果/發展
  • 簡介、定義
  • 市場規模預測 (以金額為準):各產品種類
    • 套件、試劑
    • 設備
  • 主要趨勢
  • 市場魅力:各產品種類

第6章 全球輸血診斷市場分析、預測:各應用領域

  • 主要調查結果/發展
  • 簡介、定義
  • 市場規模預測 (以金額為準):各應用領域
    • 血型判斷
    • 疾病篩檢
  • 主要趨勢
  • 市場魅力:各應用領域

第7章 全球輸血診斷市場分析、預測:各終端用戶

  • 主要調查結果/發展
  • 簡介、定義
  • 市場規模預測 (以金額為準):各終端用戶
    • 醫院
    • 診斷實驗室
    • 血庫
    • 其他
  • 主要趨勢
  • 市場魅力:各終端用戶

第8章 全球輸血診斷市場分析、預測:各地區

  • 政策、規定
  • 市場規模預測 (以金額為準):各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力:各地區

第9章 北美的輸血診斷市場分析、預測

  • 市場規模預測 (以金額為準):各國
    • 美國
    • 加拿大
  • 市場規模預測 (以金額為準):各產品類型
  • 市場規模預測 (以金額為準):各應用領域
  • 市場規模預測 (以金額為準):各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各應用領域
    • 各終端用戶

第10章 歐洲的輸血診斷市場分析、預測

第11章 亞太地區的輸血診斷市場分析、預測

第12章 南美的輸血診斷市場分析、預測

第13章 中東、非洲的輸血診斷市場分析、預測

第14章 競爭情形

  • 市場佔有率分析:各企業
  • 競爭矩陣
  • 企業簡介
    • Abbott Laboratories
    • BAG Health Care GmbH
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • DiaSorin S.p.A
    • Grifols, S.A.
    • Hologic, Inc.
    • Immucor, Inc.
    • Ortho-Clinical Diagnostics, Inc.
    • Quotient, Ltd.
    • Siemens Healthineers

第15章 要點

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Blood Transfusion Diagnostics Market - Overview

Blood transfusion diagnostics include instruments such as analyzers and centrifuges, and kits & reagents used for various tests such as blood grouping and disease screening for donors as well as patients. Blood screening is a major step in the pre-transfusion process. The report on the global blood transfusion diagnostics market analyzes the current and future prospects of the market. The report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by region, in terms of revenue %, for 2016.

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the blood transfusion diagnostics market, along with Porter's Five Forces Analysis, of the global market has been provided in this report. Market revenue analysis for all the above mentioned segments and sub segments has been provided for the forecast period from 2017 to 2025, considering 2016 as the base year and 2015 as the historical year, along with compound annual growth rate (CAGR %) for the forecast period from 2017 to 2025. Market share estimations were based on in-depth analysis and study of products, and their features, prices, etc.

This report provides in-depth analysis of the global blood transfusion diagnostics market. Stakeholders of this report include companies engaged in the manufacture of blood transfusion diagnostics. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends, and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the blood transfusion diagnostics market. Furthermore, the report incorporates market attractiveness analysis by region that depicts the most attractive and significant region in the global market.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews with key opinion leaders (KOL), and forms the bulk of the research. Secondary research includes information collected from various sources by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.

Based on product type, the global blood transfusion diagnostics market has been segmented into instruments and kits & reagents. In terms of application, the global market has been categorized into blood grouping and disease screening. Disease screening has been classified into molecular disease screening and serological disease screening. Based on end-user, the global blood transfusion diagnostics market has been divided into hospitals, diagnostic laboratories, blood banks, plasma fractionation companies, and others.

In terms of region, the global blood transfusion diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further segmented into major countries and sub-regions such as the U.S., Canada, Germany, the U.K., France, Italy, Spain, Rest of Europe, China, Japan, India, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, and Rest of MEA. The report also comprises a list of major players in the market, their SWOT analysis, market share of these players in the blood transfusion diagnostics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include Grifols S.A., Immucor Inc., Bio-Rad Laboratories Inc., Abbott, DiaSorin S.p.A., Ortho Clinical Laboratories, Quotient Limited, and F. Hoffman-La Roche Ltd.

The global blood transfusion diagnostics market has been segmented as follows:

Global Blood Transfusion Diagnostics Market, by Product

  • Instruments
  • Kits & Reagents

Global Blood Transfusion Diagnostics Market, by Application

  • Blood Grouping
  • Disease Screening
  • Molecular Disease Screening
  • Serological Disease Screening

Global Blood Transfusion Diagnostics Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Plasma Fractionation Companies
  • Others

Global Blood Transfusion Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Transfusion Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2015-2025
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Spend For Plasma Testing For Infectious Diseases (US$ Mn), by Plasma Fractionation Companies, 2015

6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2015-2025
    • 6.3.1. Instruments
    • 6.3.2. Kits & Reagents
  • 6.4. Market Attractiveness, by Product Type

7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2015-2025
    • 7.3.1. Blood Grouping
    • 7.3.2. Disease Screening
      • 7.3.2.1. Serological Disease Screening
      • 7.3.2.2. Molecular Disease Screening
  • 7.4. Market Attractiveness, by Application

8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2015-2025
    • 8.3.1. Hospitals
    • 8.3.2. Blood Banks
    • 8.3.3. Diagnostic Laboratories
    • 8.3.4. Plasma Fractionation Companies
    • 8.3.5. Others
  • 8.4. Market Attractiveness, by End-user

9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Blood Transfusion Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2015-2025
    • 10.2.1. Instruments
    • 10.2.2. Kits & Reagents
  • 10.3. Market Value Forecast, by Application, 2015-2025
    • 10.3.1. Blood Grouping
    • 10.3.2. Disease Screening
      • 10.3.2.1. Serological Disease Screening
      • 10.3.2.2. Molecular Disease Screening
  • 10.4. Market Value Forecast, by End-user, 2015-2025
    • 10.4.1. Hospitals
    • 10.4.2. Blood Banks
    • 10.4.3. Diagnostic Laboratories
    • 10.4.4. Plasma Fractionation Companies
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by Country, 2015-2025
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2015-2025
    • 11.2.1. Instruments
    • 11.2.2. Kits & Reagents
  • 11.3. Market Value Forecast, by Application, 2015-2025
    • 11.3.1. Blood Grouping
    • 11.3.2. Disease Screening
      • 11.3.2.1. Serological Disease Screening
      • 11.3.2.2. Molecular Disease Screening
  • 11.4. Market Value Forecast, by End-user, 2015-2025
    • 11.4.1. Hospitals
    • 11.4.2. Blood Banks
    • 11.4.3. Diagnostic Laboratories
    • 11.4.4. Plasma Fractionation Companies
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2015-2025
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2015-2025
    • 12.2.1. Instruments
    • 12.2.2. Kits & Reagents
  • 12.3. Market Value Forecast, by Application, 2015-2025
    • 12.3.1. Blood Grouping
    • 12.3.2. Disease Screening
      • 12.3.2.1. Serological Disease Screening
      • 12.3.2.2. Molecular Disease Screening
  • 12.4. Market Value Forecast, by End-user, 2015-2025
    • 12.4.1. Hospitals
    • 12.4.2. Blood Banks
    • 12.4.3. Diagnostic Laboratories
    • 12.4.4. Plasma Fractionation Companies
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2015-2025
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2015-2025
    • 13.2.1. Instruments
    • 13.2.2. Kits & Reagents
  • 13.3. Market Value Forecast, by Application, 2015-2025
    • 13.3.1. Blood Grouping
    • 13.3.2. Disease Screening
      • 13.3.2.1. Serological Disease Screening
      • 13.3.2.2. Molecular Disease Screening
  • 13.4. Market Value Forecast, by End-user, 2015-2025
    • 13.4.1. Hospitals
    • 13.4.2. Blood Banks
    • 13.4.3. Diagnostic Laboratories
    • 13.4.4. Plasma Fractionation Companies
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2015-2025
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2015-2025
    • 14.2.1. Instruments
    • 14.2.2. Kits & Reagents
  • 14.3. Market Value Forecast, by Application, 2015-2025
    • 14.3.1. Blood Grouping
    • 14.3.2. Disease Screening
      • 14.3.2.1. Serological Disease Screening
      • 14.3.2.2. Molecular Disease Screening
  • 14.4. Market Value Forecast, by End-user, 2015-2025
    • 14.4.1. Hospitals
    • 14.4.2. Blood Banks
    • 14.4.3. Diagnostic Laboratories
    • 14.4.4. Plasma Fractionation Companies
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2015-2025
    • 14.5.1. Saudi Arabia
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Company Profiles

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company, 2017 (estimated)
  • 15.3 Company Profiles
    • 15.3.1 Grifols S.A.
      • 15.3.1.1 Company Details
      • 15.3.1.2 Business Overview
      • 15.3.1.3 Financial Overview
      • 15.3.1.4 Strategic Overview
      • 15.3.1.5 SWOT Analysis
    • 15.3.2 Immucor, Inc.
      • 15.3.2.1 Company Details
      • 15.3.2.2 Business Overview
      • 15.3.2.3 Financial Overview
      • 15.3.2.4 Strategic Overview
      • 15.3.2.5 SWOT Analysis
    • 15.3.3 Ortho Clinical Diagnostics
      • 15.3.3.1 Company Details
      • 15.3.3.2 Business Overview
      • 15.3.3.3 Financial Overview
      • 15.3.3.4 Strategic Overview
      • 15.3.3.5 SWOT Analysis
    • 15.3.4 Abbott
      • 15.3.4.1 Company Details
      • 15.3.4.2 Business Overview
      • 15.3.4.3 Financial Overview
      • 15.3.4.4 Strategic Overview
      • 15.3.4.5 SWOT Analysis
    • 15.3.5 Bio-Rad Laboratories, Inc.
      • 15.3.5.1 Company Details
      • 15.3.5.2 Business Overview
      • 15.3.5.3 Financial Overview
      • 15.3.5.4 Strategic Overview
      • 15.3.5.5 SWOT Analysis
    • 15.3.6 F. Hoffman-La Roche Ltd.
      • 15.3.6.1 Company Details
      • 15.3.6.2 Business Overview
      • 15.3.6.3 Financial Overview
      • 15.3.6.4 Strategic Overview
      • 15.3.6.5 SWOT Analysis
    • 15.3.7 QUOTIENT LIMITED
      • 15.3.7.1 Company Details
      • 15.3.7.2 Business Overview
      • 15.3.7.3 Financial Overview
      • 15.3.7.4 Strategic Overview
      • 15.3.7.5 SWOT Analysis
    • 15.3.8 BAG Healthcare GmBH
      • 15.3.8.1 Company Details
      • 15.3.8.2 Business Overview
      • 15.3.8.3 Financial Overview
      • 15.3.8.4 Strategic Overview
      • 15.3.8.5 SWOT Analysis
    • 15.3.9 DiaSorin S.p.A.
      • 15.3.9.1 Company Details
      • 15.3.9.2 Business Overview
      • 15.3.9.3 Financial Overview
      • 15.3.9.4 Strategic Overview
      • 15.3.9.5 SWOT Analysis
    • 15.3.10 Hologic, Inc.
      • 15.3.10.1 Company Details
      • 15.3.10.2 Business Overview
      • 15.3.10.3 Financial Overview
      • 15.3.10.4 Strategic Overview
      • 15.3.10.5 SWOT Analysis

List of Table

  • Table 01 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 02 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015-2025
  • Table 03 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015-2025
  • Table 04 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 05 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Region, 2015-2025
  • Table 06 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country, 2015-2025
  • Table 07 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 08 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015-2025
  • Table 09 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015-2025
  • Table 10 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End User, 2015-2025
  • Table 11 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 12 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 13 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015-2025
  • Table 14 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015-2025
  • Table 15 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 16 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 17 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 18 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015-2025
  • Table 19 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015-2025
  • Table 20 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End User, 2015-2025
  • Table 21 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 22 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 23 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015-2025
  • Table 24 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015-2025
  • Table 25 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 26 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 27 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 28 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015-2025
  • Table 29 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015-2025
  • Table 30 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast,by End-user, 2015-2025

List of Figures

  • Figure 1: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 2: Global Blood Transfusion Diagnostics Market Value Share, by Region (2016)
  • Figure 4: Global Blood Transfusion Diagnostics Market Value Share, by Application (2016)
  • Figure 3: Global Blood Transfusion Diagnostics Market Value Share, by Product Type (2016)
  • Figure 5: Global Blood Transfusion Diagnostics Market Value Share, by End-user (2016)
  • Figure 6: Global blood transfusion diagnostics Market Value Share, by Product Type, 2017 and 2025
  • Figure 7: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2015-2025
  • Figure 8: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Kits & Reagents,
  • Figure 9: Global Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017-2025
  • Figure 10: Global Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
  • Figure 11: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Grouping, 2015-2025
  • Figure 12: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Screening,
  • Figure 13: Global Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017-2025
  • Figure 14: Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
  • Figure 15: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015-2025
  • Figure 16: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Banks,
  • Figure 17: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2015-2025
  • Figure 18: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Plasma Fractionation Companies, 2015-2025
  • Figure 19: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015-2025
  • Figure 20: Global Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017-2025
  • Figure 21: Global Blood Transfusion Diagnostics Market Value Share, by Region, 2017 and 2025
  • Figure 22: Global Blood Transfusion Diagnostics Market Attractiveness, by Region, 2017-2025
  • Figure 23: North America Blood Transfusion Diagnostics Market Value Share, by Country, 2017 and 2025
  • Figure 24: North America Blood Transfusion Diagnostics Market Attractiveness, by Country, 2017-2025
  • Figure 25: North America Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
  • Figure 26: North America Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017-2025
  • Figure 27: North America Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
  • Figure 28: North America Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017-2025
  • Figure 29: North America Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
  • Figure 30: North America Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017- 2025
  • Figure 31: Europe Blood Transfusion Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 32: Europe Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-region, 2017-2025
  • Figure 33: Europe Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
  • Figure 34: Europe Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017-2025
  • Figure 35: Europe Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
  • Figure 36: Europe Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017-2025
  • Figure 37: Europe Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
  • Figure 38: Europe Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017-2025
  • Figure 39: Asia Pacific Blood Transfusion Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 40: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-region, 2017-2025
  • Figure 41: Asia Pacific Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
  • Figure 42: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017-2025
  • Figure 43: Asia Pacific Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
  • Figure 44: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017-2025
  • Figure 45: Asia Pacific Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
  • Figure 46: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017-2025
  • Figure 47: Latin America Blood Transfusion Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 48: Latin America Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-Region, 2017-2025
  • Figure 49: Latin America Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
  • Figure 50: Latin America Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017-2025
  • Figure 51: Latin America Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
  • Figure 52: Latin America Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017-2025
  • Figure 53: Latin America Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
  • Figure 54: Latin America Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017-2025
  • Figure 55: Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by Country/Sub-Region, 2017 and 2025
  • Figure 56: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-region, 2017-2025
  • Figure 57: Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
  • Figure 58: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017-2025
  • Figure 59: Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
  • Figure 60: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017-2025
  • Figure 61: Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
  • Figure 62: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017-2025
  • Figure 63: Global Blood Transfusion Diagnostics Market Share (%) & Market Share Range (%), by Company, 2017 (Estimated)
  • Figure 64: Grifols S.A. Breakdown of Net Sales, by Business Segment, 2017
  • Figure 65: Grifols S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 66: DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2017
  • Figure 67: DiaSorin S.p.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 68: Immucor, Inc., Breakdown of Net Sales, by Product Group, 2016
  • Figure 69: Immucor, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
  • Figure 70: Abbott Breakdown of Revenue (US$ Mn), by Region, 2016
  • Figure 71: Abbott Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • Figure 72: Bio-Rad Laboratories, Inc., Breakdown of Net Sales, by Region, 2016
  • Figure 73: Bio-Rad Laboratories, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • Figure 74: Hologic, Inc., Breakdown of Net Sales, by Region, 2016
  • Figure 75: Hologic, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2017
  • Figure 76: QUOTIENT LIMITED, Breakdown of Net Sales, by Product Group, 2017
  • Figure 77: QUOTIENT LIMITED, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 78: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Business Segment, 2017
  • Figure 79: F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017